Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D06NIT
|
||||
| Former ID |
DIB012770
|
||||
| Drug Name |
PF-4181366
|
||||
| Synonyms |
PDE9A inhibitor (cognitive deficit), Pfizer
|
||||
| Indication | Cognitive disorders [ICD9: 290-294, 294.0, 780.09, 780.9, 780.93; ICD10:F01-F07, F04, F05, R41.3] | Investigative | [543409] | ||
| Company |
Pfizer Inc
|
||||
| Canonical SMILES |
c1(nc2c(c(=O)[nH]1)cnn2C1CCCC1)[C@@H]1CN(C[C@H]1C)Cc1cc<br />2nccnc2cc1
|
||||
| Target and Pathway | |||||
| Target(s) | Phosphodiesterase (PDE) 9 | Target Info | Inhibitor | [543409] | |
| KEGG Pathway | Purine metabolism | ||||
| Pathway Interaction Database | Regulation of Androgen receptor activity | ||||
| Reactome | cGMP effects | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.